Skip to main content

Schmertzler Michael's Form 4 filing

PTC Therapeutics, Inc.PTCT · filed Aug 21, 2026

Accession no.
0001288952-26-000004
Filed
Aug 21, 2026, 5:20 PM ET
Trade date
Aug 19-20, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions. Open-market sales total $1.81M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schmertzler MichaelCIK 0001288952Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2026Common StockSSaleDisposed−5,335$72.86F2−$388,708.11,381,259Indirect
Aug 19, 2026Common StockSSaleDisposed−7,165$73.67F4−$527,845.551,374,094Indirect
Aug 20, 2026Common StockSSaleDisposed−9,419$70.78F5−$666,676.821,364,675Indirect
Aug 20, 2026Common StockSSaleDisposed−2,390$71.88F6−$171,793.21,362,285Indirect
Aug 20, 2026Common StockSSaleDisposed−691$72.92F7−$50,387.721,361,594Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.33 to $73.32 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.33 to $74.02 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.50 to $71.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.50 to $72.46 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.60 to $73.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)